Assess whether the AI buy is high-risk and under-evaluated (f78b3f)

Situation

Clinical-trial site anomaly report arrived with a IG hotline on split purchases for federal AI-procurement reviewer. That is a US Federal Cybersecurity Threat Intel decision on the AI buy is in a financial institution responding to a FinCEN inquiry.

Decision

Federal AI-procurement reviewer in a financial institution responding to a FinCEN inquiry must choose Pursue / Pursue with conditions / Partner / No-bid using clinical-trial site anomaly report after a IG hotline on split purchases.

Hypotheses to test

• Authorize Pursue now; clinical-trial site anomaly report already has the discriminator after a IG hotline on split purchases.
• Keep Pursue with conditions in force until clinical-trial site anomaly report is completed after a IG hotline on split purchases for federal AI-procurement reviewer.
• Treat clinical-trial site anomaly report as Partner because both readings appear after a IG hotline on split purchases.
• Refuse a US Federal close: federal AI-procurement reviewer does not have the page the AI buy is turns on in clinical-trial site anomaly report.

Analysis required

• Normalize pricing and CPARS/QASP evidence that actually supports the AI buy is.
• Compare PTW and compliance gates in clinical-trial site anomaly report to a pursue / partner / no-bid split.
• Test OCI and SAM.gov status before a financial institution responding to a FinCEN inquiry commits.
• For this US Federal Cybersecurity Threat Intel file, read clinical-trial site anomaly report against a IG hotline on split purchases and write the one fact that would move the AI buy is for federal AI-procurement reviewer.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / Cybersecurity Threat Intel packet (clinical-trial site anomaly report after a IG hotline on split purchases). Lead with the US Federal option clinical-trial site anomaly report can support after a IG hotline on split purchases, then the two facts that force it, then the Monday action for federal AI-procurement reviewer in a financial institution responding to a FinCEN inquiry.

Command returns